Machine Learning

Malbek launches BusinessIQ, claiming to redefine contract management by turning static legal documents into a source of real-time strategic intelligence.

A new AI platform is the first to get EU approval for predicting fertility treatment timing, promising to boost success rates and ease clinic workloads.

A landmark partnership with Blue Star Innovation Partners will fuel IntusCare's AI platform, aiming to revolutionize the complex, high-growth PACE market.

Calamos's new CAGE ETF brings a complex, high-growth institutional strategy to retail investors. But does this powerful innovation come with too much risk?

With key advisory appointments, NeuraClick aims to overcome long-standing hurdles in peptide drug development for complex brain and metabolic disorders.

As attackers use AI and proxies to hide in plain sight, Spur Intelligence's rapid growth shows why deep IP intelligence is becoming a top business priority.

TEDCO's latest funding round seeds 13 university-born ventures, tackling everything from hereditary hearing loss and cancer to environmental monitoring.

A new biotech player is advancing a first-in-class cancer drug that combines two payloads to fight tumors that have become resistant to current therapies.

Apryse's new ICR technology lets companies digitize handwritten documents securely in-house, unlocking a final frontier of data for AI automation.

Backed by Bain Capital and a veteran team, the new biotech has a de-risked pipeline from Bristol Myers Squibb aimed at transforming care for lupus and more.

Investors eye BioCryst's May 6th report for insights into ORLADEYO's growth, a pivotal acquisition, and its strategy in the competitive rare disease market.

Scientists have created the first continent-wide map of bird flu's spread, explaining human cases and assessing the risk of a future pandemic.

Backed by DJI's tech prowess, Amflow unveils its PX and PR eMTBs with monstrous power, smart features, and lightweight frames, aiming to redefine the market.

Pre-rolled joints are now the #1 cannabis product by units sold, a new report reveals. Discover the strategies and innovations fueling this market takeover.

A new service from Alida Biosciences simultaneously reads three key RNA modifications, opening a new frontier in disease diagnostics and biological research.

Promising early safety data for a novel drug, KM-023, brings a potential first-ever targeted treatment for the devastating Olmsted syndrome a step closer.

With strategic cargo theft costing billions, a new AI platform offers real-time biometric verification to secure shipments before they ever move.

Instem hires AI regulatory expert Szczepan Baran to embed submission-ready science into preclinical R&D, aiming to move beyond hype to validated results.

At a major oncology conference, Zephyr AI will showcase AI that predicts patient response to targeted therapies, aiming to personalize cancer treatment.

A new 'pure-play' space tech ETF, ORBX, aims to give investors a direct route into the booming commercial space race. Here is how it works.